Brochure | July 1, 2022

GenVoy-ILM™ T Cell Kit For mRNA, Ignite™

Scale Up Your Cell Therapy with Lipid Nanoparticles

Current gene delivery methods have significant challenges, hindering future innovations in cell therapies. Non-viral electroporation method can be harsh on cells, making it difficult to generate quality cells at high yields, whereas conventional viral vector delivery method is expensive and cumbersome to manufacture. Lipid nanoparticles (LNPs) enable researchers to establish a clinically-relevant and scalable method for ex vivo gene delivery and editing to advance the development of cell therapies.

GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an off-the-shelf lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells. This kit is available in two sizes: 3 mL and 6 mL.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene